After three sessions of gains, equities headed south on Thursday as investors responded cautiously to mixed US economic data, including worse-than-expected housing sales figures and better-than-expected unemployment data.
One of only a handful of upward stocks on the Paris bourse was Sanofi-Aventis, the French pharmaceuticals group, which announced an alliance with Exelixis, the US drug development and research company.
